Advanced Search

 

Study ID Status Title Patient Level Data
200260 Completed An Open-Label, Randomised, Two Treatment, Four-Way Cross-Over (Replicate Design), Two Sequence, Repeat Dose, Single Centre Study in Healthy Volunteers to Compare the Pharmacokinetics of Fluticasone Propionate/Salmeterol (100/50 mcg) Delivered Via the Low Airflow Resistance ROTAHALER Inhaler Relative to Fluticasone Propionate/Salmeterol (100/50 mcg) Delivered Via the DISKUS Inhaler Study Listed on ClinicalStudyDataRequest.com
200262 Completed A FTIH study with GSK3008348 in healthy volunteers and patients with Idiopathic Pulmonary Fibrosis
200276 Completed Meta-Analysis of Liver Chemistry Abnormalities with GW786034 (Pazopanib) Treatment in Advanced/Metastatic Renal Cell Carcinoma, Soft Tissue Sarcoma and Ovarian Cancer
200277 Active not recruiting Meta-Analysis Plan for liver analyses with GW786034 (pazopanib) treatment in advanced/metastatic renal cell carcinoma and soft tissue sarcoma to support a regulatory post marketing requirement
200281 Recruiting Drug Use Investigation of VOTRIENT® Tablets (Investigation in Patients with Renal Cell Carcinoma)
200284 Completed A Relative Bioavailability Study to Compare the Pharmacokinetics of a Fixed Dose Combination of Fluticasone Furoate and Levocabastine with Levocabastine and Fluticasone Furoate Alone Study Listed on ClinicalStudyDataRequest.com
200285 Completed A randomized, double-blind, placebo controlled, 3 way cross over study in subjects with allergic rhinitis to assess the effect of intranasal repeat doses of levocabastine when administered once daily or twice daily on the symptoms of rhinitis in an allergen challenge chamber Study Listed on ClinicalStudyDataRequest.com
200286 Completed A randomised, double-blind, placebo-controlled, 3 way, incomplete block cross over study in subjects with allergic rhinitis to assess the effect of once daily single and repeat doses of intranasal Fluticasone furoate/Levocabastine fixed dose combination (FDC) relative to Levocabastine and Fluticasone furoate alone on the onset and magnitude of symptoms of rhinitis in an allergen challenge chamber Study Listed on ClinicalStudyDataRequest.com
200293 Recruiting Drug Use Investigation of RELVAR® (vilanterol trifenatate and fluticasone furoate) for Asthma Patients
200294 Not yet recruiting Special Drug Use Investigation of RELVAR® for Asthma patients
200301 Completed An open-label study of inhaler device attributes investigating critical and overall errors, ease of use, and preference between a number of inhaler devices (ELLIPTA, TURBUHALER, HANDIHALER, BREEZHALER, MDI, and DISKUS/ACCUHALER) in adult subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
200311 Recruiting Drug Use Investigation of ANORO ELLIPTA inhaler
200317 Active not recruiting Belimumab 10mg/kg versus Placebo Post-hoc Analysis of Corticosteroid Use across 52 Weeks of Treament (BLISS-52 & BLISS-76 Meta-analysis)
200330 Completed An open-label study of inhaler device attributes investigating critical and overall errors, and ease of use and preference between a number of inhaler devices (ELLIPTA, DISKUS/ACCUHALER, TURBUHALER, and MDI) in adult subjects with asthma (Study 200330)
200338 Completed An Open-label Single-dose Pharmacokinetic Study of an Oral Formulation in Tablets Containing Eltrombopag 50 mg (Revolade, Glaxosmithkline Mexico, S.A. De C.V.) in Healthy Volunteers Under Fasting Conditions
200339 Completed An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector that Administers Belimumab Subcutaneously in Subjects with Systemic Lupus Erythematosus (SLE) Study Listed on ClinicalStudyDataRequest.com
200341 Completed Evidence Synthesis and Mixed Treatment Comparison of Efficacy of Treatments for the Maintenance of Asthma
200342 Completed Evidence Synthesis and Mixed Treatment Comparison of Efficacy of Treatments for the Maintenance of COPD
200347 Completed Indirect cost of illness study of moderate and severe asthma in Quebec
200367 Completed PGx6951: Analysis of influence of GLCCI1 variant rs37973 on inhaled corticosteroid response in COPD patients treated with fluticasone furoate in HZC112206 and HZC112207
200372 Completed A randomized, open-labelled non-drug interventional, cross-over, dry powder inhaler device preference study to compare “ease of use” of ELLIPTA (TM) inhaler with BREEZHALER (TM) inhaler in inhalation-device naïve Japanese volunteers aged 40 years or older
200374 Not yet recruiting Benefit of patient referral to epilepsy centers in Japan
200381 Completed Post-hoc analysis of Japanese phase II data on initial Parkinson’s disease motor dysfunctions (Study ID: 200381)
200382 Completed Cost-effectiveness of combined use of ropinirole controlled-release and L-dopa compared with L-dopa monotherapy in patients with Parkinson's disease
200385 Not yet recruiting Retrospective survey of lasting, treatment-free responders with ITP after cessation of drug therapy(RELIANT). Preliminary survey.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.